VEGFA and neoplasm: Moreover, SPM analogs inhibited Vascular Endothelial Growth Factor (VEGF)-induced endothelial permeability by stabilizing the Vascular Endothelial (VE)-cadherin/ß-catenin-dependent adherens junctions to protect patients from tumor extravasation across endothelial barriers [24].